Gerald has type 2 diabetes
  •  

Protein delivery devices

Our ambition

In 1985, Novo Nordisk introduced the world’s first insulin pen. The insulin pen gave people with diabetes a convenient device to inject insulin several times a day. Since then, we have made extensive efforts in research and development of new delivery systems which will help people with chronic diseases manage protein therapy even better.

Our partnering focus

New injection device concepts and technologies

  • Injection of soluble protein formulations
  • Injection of lyophilised protein formulations

New infusion device concepts and technologies

  • Subcutaneous insulin infusion
  • Intravenous infusion for haemophilia therapy

New primary packaging concepts and technologies

Read more about Device R&D

Contact us

For further information please contact  Device R&D Innovation Sourcing


  •  

Download partnering for innovation bruchure

  •  
  •  

Where to meet us

We are attending events all over the world to meet with new potential partners.
Event Calendar

  •  
  •  

Contact us

For further information about our partnering focus in protein delivery, please contact: Diabetes Sourcing

  •